BeiGene (BGNE)
(Delayed Data from NSDQ)
$160.77 USD
-1.40 (-0.86%)
Updated May 14, 2024 04:00 PM ET
After-Market: $160.79 +0.02 (0.01%) 4:28 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-2.25 | -0.58% |
Earnings Summary
For their last quarter, BeiGene (BGNE) reported earnings of -$2.41 per share, beating the Zacks Consensus Estimate of $-2.98 per share. This reflects a positive earnings surprise of 19.13%. Look out for BGNE's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$2.25 per share, reflecting a year-over-year increase of 38.19%.
Earnings History
Price & Consensus
Zacks News for BGNE
3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024
BGNE: What are Zacks experts saying now?
Zacks Private Portfolio Services